논문정보 : Lee EK, Revil C, Ngoh CA, Lister J, Kwon JM, Park MH, et al. Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea. Clin Ther. 2012;34(6):1408-19.
논문정보 : Lee EK, Kim BY, Lim JY, Park MH. Different policy outcomes of the new drugs and currently listed drugs under the positive list system in South Korea. Value Health. 2012;15(1 Suppl):S100-3.
논문보기 : 10.1016/j.jval.2011.11.017
논문정보 : Kwon JM, Cho SK, Kim JH, Lee EK. Medical costs for Korean patients with rheumatoid arthritis based on the national claims database. Rheumatol Int. 2012;32(9):2893-9.
논문보기 : 10.1007/s00296-011-2117-2
논문정보 : Ha D, Choi Y, Kim DU, Chung KH, Lee EK. A comparative analysis of the impact of a positive list system on new chemical entity drugs and incrementally modified drugs in South Korea. Clin Ther. 2011;33(7):926-32.
논문정보 : Bae JY, Kim CH, Lee EK. Evaluation of cost-utility of varenicline compared with existing smoking cessation therapies in South Korea. Value Health. 2009;12 Suppl 3:S70-3.
논문정보 : Lee EK, Malone DC. Comparison of peptic-ulcer drug use and expenditures before and after the implementation of a government policy to separate prescribing and dispensing practices in South Korea. Clin Ther. 2003;25(2):578-92.